Aptose Biosciences GAAP EPS of -$36.38
2025-03-28 08:17:26 ET
More on Aptose Biosciences
- Aptose Biosciences approves 1-for-30 reverse share split to restore Nasdaq compliance
- Aptose Biosciences announces resale of 12.03M shares by Keystone Capital Partners
- Seeking Alpha’s Quant Rating on Aptose Biosciences
- Historical earnings data for Aptose Biosciences
- Financial information for Aptose Biosciences
Read the full article on Seeking Alpha
For further details see:
Aptose Biosciences GAAP EPS of -$36.38NASDAQ: APTO
APTO Trading
-16.37% G/L:
$1.71 Last:
670,384 Volume:
$1.99 Open:



